These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 3123582

  • 21. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ, Closs O, Belehu A.
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [Abstract] [Full Text] [Related]

  • 22. Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy.
    Yoder L, Naafs B, Harboe M, Bjune G.
    Lepr Rev; 1979 Jun; 50(2):113-21. PubMed ID: 396427
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Importance of immune reactions in leprosy.
    Harboe M.
    Ethiop Med J; 1976 Oct; 14(4):205-12. PubMed ID: 799966
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of treatment on antibody activity against Mycobacterium leprae antigen 7 in tuberculoid leprosy.
    Dahle JS, van Diepen TW, Touw Langendijk EJ, Harboe M, Belehu A.
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):312-20. PubMed ID: 6358062
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Variation of in vitro lymphocyte responses to M. leprae antigen in borderline tuberculoid leprosy patients.
    Bjune G.
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):30-40. PubMed ID: 6154019
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The immunobiology of leprosy.
    Kaplan G, Cohn ZA.
    Int Rev Exp Pathol; 1986 Mar; 28():45-78. PubMed ID: 3516911
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin A.
    Beck JS, Morley SM, Gibbs JH, Potts RC, Ilias MI, Kardjito T, Grange JM, Stanford J, Brown RA.
    Clin Exp Immunol; 1986 Jun; 64(3):484-94. PubMed ID: 3539419
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.